Clinical Trials Browser

Phase 3 × Epirubicin × Tumor-Agnostic × Clear all

NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Phase 3 Unknown

Neoplasms, Unknown Primary

NCT00140075 2011-05-26

Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Phase 3 Completed

Adenocarcinoma